Attachment

human gamma-globin gene is influenced by chromosomal position effects and vector copy number. Blood. 2003;101(6):2175-83. 44. Pestina TI, Hargrove PW, Jay D, Gray JT, Boyd KM, and Persons DA. Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. Mol Ther. 2009;17(2):245-52. 45. Pestina TI, Hargrove PW, Zhao H, Mead PE, Smeltzer MP, Weiss MJ, et al. Amelioration of murine sickle cell disease by nonablative conditioning and gamma-globin gene-corrected bone marrow cells. Mol Ther Methods Clin Dev. 2015;2:15045. 46. Perumbeti A, Higashimoto T, Urbinati F, Franco R, Meiselman HJ, Witte D, et al. A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction. Blood. 2009;114(6):1174-85. 47. Ni S, Bernt K, Gaggar A, Li ZY, Kiem HP, and Lieber A. Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. Hum Gene Ther. 2005;16(6):664-77. 48. Banskota S, Raguram A, Suh S, Du SW, Davis JR, Choi EH, et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell. 2022;185(2):250-65 e16. 49. Xue L, Gong N, Shepherd SJ, Xiong X, Liao X, Han X, et al. Rational Design of Bisphosphonate Lipidlike Materials for mRNA Delivery to the Bone Microenvironment. J Am Chem Soc. 2022. 50. Rurik JG, Tombacz I, Yadegari A, Mendez Fernandez PO, Shewale SV, Li L, et al. CAR T cells produced in vivo to treat cardiac injury. Science. 2022;375(6576):91-6. 51. Grunewald J, Zhou R, Iyer S, Lareau CA, Garcia SP, Aryee MJ, et al. CRISPR DNA base editors with reduced RNA off-target and self-editing activities. Nat Biotechnol. 2019;37(9):1041-8. 52. Rees HA, Wilson C, Doman JL, and Liu DR. Analysis and minimization of cellular RNA editing by DNA adenine base editors. Sci Adv. 2019;5(5):eaax5717. 53. Wang H-J, Germond A, Li C, Gil S, Kim J, Kiem HP, et al. In vivo HSC transduction in rhesus macaques with an HDAd5/3+ vector targeting desmoglein 2 and transiently over-expressing cxcr4. Blood Advances. 2022;PMID: 35679480. 54. Li C, Goncalves KA, Rasko T, Pande A, Gil S, Liu Z, et al. Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice. Blood Adv. 2021;5(5):1239-49.